Sponsor:
PureTech
Code:
NCT05829226
Conditions
AML, Adult Recurrent
MDS
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
LYT-200
Venetoclax
Azacitidine
Decitabine
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by PureTech on 2024-01-11.